Fulcrum Therapeutics, Inc. (FULC)

NASDAQ: FULC · Real-Time Price · USD

8.38

-0.35 (-4.01%)

At close: Feb 27, 2026, 4:00 PM EST

8.30

-0.08 (-0.95%)

After-hours: Feb 27, 2026, 5:21 PM EST

Fulcrum Therapeutics Market Cap

Fulcrum Therapeutics has a market cap or net worth of $558.11 million as of February 27, 2026. Its market cap has increased by 190.65% in one year.

Market Cap

558.11M

Enterprise Value

212.25M

1-Year Change

190.65%

Ranking

#2962

Market Cap Chart

Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $301.64M to $558.11M, an increase of 85.02%. That is a compound annual growth rate of 9.74%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2026	558.11M	-25.20%
Dec 31, 2025	746.12M	194.32%
Dec 31, 2024	253.51M	-39.25%
Dec 29, 2023	417.30M	10.13%
Dec 30, 2022	378.93M	-47.15%
Dec 31, 2021	716.95M	124.42%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Ocugen	596.76M
Design Therapeutics	594.70M
Neumora Therapeutics	593.09M
CorMedix	561.77M
Larimar Therapeutics	560.68M
Contineum Therapeutics	560.36M
Rocket Pharmaceuticals	542.19M
Altimmune	539.75M

Market Cap Rankings